CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossner, P.
Right arrow Articles by Santella, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossner, P., Jr.
Right arrow Articles by Santella, R. M.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 811-815, April 2006
© 2006 American Association for Cancer Research

OGG1 Polymorphisms and Breast Cancer Risk

Pavel Rossner, Jr.1,6, Mary Beth Terry2, Marilie D. Gammon5, Fang Fang Zhang2, Susan L. Teitelbaum3, Sybil M. Eng4, Sharon K. Sagiv5, Mia M. Gaudet5, Alfred I. Neugut2 and Regina M. Santella1

Departments of 1 Environmental Health Sciences and 2 Epidemiology, Mailman School of Public Health, Columbia University; 3 Department of Community and Preventive Medicine, Mt. Sinai School of Medicine; 4 Pfizer, Inc., New York, New York; 5 Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, North Carolina; and 6 Laboratory of Genetic Ecotoxicology, Health Institute of Central Bohemia and Institute of Experimental Medicine AS CR, Prague, Czech Republic

Requests for reprints: Pavel Rossner, Jr., Institute of Experimental Medicine, LGE, Videnska 1083, Praha 4, Prague, Czech Republic. Phone: 420-24-106-2675; E-mail: prossner{at}biomed.cas.cz

The role of oxidative stress in breast cancer risk is still unclear. OGG1 encodes an 8-oxoguanine DNA glycosylase/AP lyase that catalyzes the removal of 8-oxodeoxyguanosine from DNA. 8-Oxodeoxyguanosine, the most abundant lesion generated by oxidative stress, is highly mutagenic. Environmental sources of oxidative stress, such as alcohol consumption, cigarette smoking, high body mass index (BMI), and low fruits and vegetables intake, may modify the association of genetic polymorphisms with breast cancer risk. We investigated the association between three genetic polymorphisms in OGG1 (Ser326Cys, 7143A/G, and 11657A/G) and breast cancer risk among 1,058 cases and 1,102 controls participating in the Long Island Breast Cancer Study Project. No associations were observed between individual OGG1 polymorphisms, haplotypes, or diplotypes and breast cancer. The association between having at least one variant allele and breast cancer risk was stronger among moderate alcohol drinkers for Ser326Cys [odds ratio (OR), 1.82; 95% confidence interval (95% CI), 1.06-3.10] relative to nondrinkers with the wild-type genotype and among those with higher BMI for 7143A/G (OR, 1.47; 95% CI, 1.10-1.96) and for 11657A/G (OR, 1.41; 95% CI, 1.05-1.88), relative to women with BMI < 25 kg/m2 and the wild-type genotype. However, the patterns were not seen for all three single nucleotide polymorphisms (SNP) nor were there any clear allele dose associations; only one interaction was statistically significant, assuming a multiplicative model (11657A/G, Pinteraction = 0.04). In summary, although we found some differences between the three OGG1 SNPs and breast cancer risk among moderate alcohol drinkers and women with higher BMI, replication of these results is needed to rule out spurious findings. In addition, data on functionality of these polymorphisms are crucial to understand if these modest differences are important. (Cancer Epidemiol Biomarkers Prev 2006;15(4):811–5)




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Huang, C. P. Dinney, X. Lin, J. Lin, H. B. Grossman, and X. Wu
High-Order Interactions among Genetic Variants in DNA Base Excision Repair Pathway Genes and Smoking in Bladder Cancer Susceptibility
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 84 - 91.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.